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Abstract 
Traumatic brain injury (TBI) is a common 
cause of death and disability in developed 
countries. It is a major cause of mortality in 
young patients worldwide. Intracranial 
hypertension is the cause of death in more 
than 80% of patients with TBI. When 
secondary lesions occur, start a number of 
mechanisms that increase the metabolic injury 
to brain tissue. Induction of hypothermia has 
been shown to alter the natural course of the 
disease process. The biological foundations 
suggest that hypothermia may have a potential 
benefit, although some publications have 
shown no improvement, it is clear that in a 
group of mostly young patients, early 
hypothermia may be beneficial. We present a 
practical review of the literature on this 
subject.  
Key words: Hypothermia, traumatic brain 
injury, intracranial hypertension. 
Introduction 
Morbidity and mortality from traumatic 
injuries are globally recognized as a severe 
health problem in constant development, 
these injuries are among the leading causes of 
death, occurs in all regions, affecting people of 
all ages and socioeconomic status. (1) 
Traumatic brain injury (TBI) is a worldwide 
health problem, (2) according to predictions, 
the neurotrauma will remain representing a 
growing number of deaths worldwide by 2020. 
(3) 
Among the TBI secondary lesions are 
increased intracranial pressure (ICH), release 
of proinflammatory mediators and free 
radicals, decreased cerebral blood flow due to 
systemic hypotension and hypoxia, which are 
all recognized risk factors for poor outcome. 
(4–6) 
A potential therapy that improves 
outcomes in specific patient populations is 
therapeutic hypothermia (TH). (7–11) 
Hypothermia has been used therapeutically 
for centuries, (12,13) and has been studied 
extensively in TBI, (14–26) as a strategy to 
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improve post-traumatic neurologic outcomes, 
(2) yet it is one of the few topics that has caused 
such debate and lack of consensus about its 
role in this type of injury. (27) 
Although there is much information about 
the pathophysiology of TBI, (28,29) has not yet 
reached the successful handover of therapeutic 
interventions seen as promising in animal 
models to clinical practice. (30) HT is 
currently recommended by the American 
Heart Association (AHA), as neuroprotective 
therapy in the post cardiac arrest care. (13,31) 
Theoretically it is indicated for the treatment 
of complications associated with TBI such as 
ICH (>20mm Hg) and status epilepticus, (32) 
but is not considered as first-line treatment for 
TBI in USA, however, it is in use for TBI in 
47% of neurotrauma centers in Japan. (33) The 
aim of this paper is to briefly review some key 
aspects regarding therapeutic HT in the 
context of TBI. 
Definition  
HT is a treatment modality conducted by 
the physician in order to reduce the core 
temperature. (13) Hypothermia is defined as a 
body temperature below 35 ºC (95 °F). It can 
be classified by their intensity in five groups: 
(34) 
• Mild: 32 a 34º C 
• Moderate: 28 a 31.9º C 
• Intense: 11 a 28º C. 
• Deep: 6 – 10 °C 
• Ultradeep: ≤5 °C 
History 
The use of HT was described by the ancient 
Egyptians, Greeks and Romans. Hippocrates 
advised covered with ice and snow in poorly 
healing wounds to reduce blood loss. Galen 
also described some uses of HT. 
In the 50s, several studies on the 
physiological effects of HT in humans were 
conducted, until now no randomized clinical 
trial. In 1972, Robert Boyle and James Curie 
and later William Osler attempted to use HT 
in the treatment of typhoid fever, immersing 
the patient in icy sea water and brine. Osler 
reported a 17% reduction in deaths of patients 
at Johns Hopkins Hospital. (34) In 1814, 
Napoleon Bonaparte´s General Surgeon, 
Baron Larrey, described the wounded soldiers 
were placed near the fires died first than those 
who were not reheated. (35) The first attempt 
was made in November 28, 1938. (36, 37) 
The potential beneficial effect of HT in the 
treatment of TBI has been reported since mid-
1940. (37) During World War II, the Nazis 
conducted studies on Jewish men to simulate 
the conditions suffered by the army and the 
fallen pilots during wartime, with the 
objectives to determine the cause of death 
from hypothermia (cardiac or metabolic), to 
establish the exact temperature at which the 
death occurred, determine the best methods of 
resuscitation, and the most appropriate type of 
protective clothing. (38–40) 
Posteriorly, with the works of Bigelow, the 
intraoperative HT was used since 1950. (41) 
Perhaps the most important lesson of the HT 
history is that it not only seeks to reduce 
metabolism, but also that mild HT is sufficient, 
that intensive care in these patients is always 
necessary, and that the implementation of 
strategies is needed. 
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Mechanism of action 
To facilitate the use of HT in specific TBI 
populations is important not only 
understanding the mechanisms of secondary 
damage in which the HT mediate, but also the 
potentially repair mechanisms that can be 
regulated by hypothermia. (42, 43) HT reduces 
histopathological damage resulting from the 
brain injury, to mediate multiple and specific 
mechanisms of secondary injury as 
consequence of TBI, such as ICH, (10, 14, 32, 
44–46) but the exact mechanisms by which HT 
has beneficial effects are unknown. 
Before 1990 it was felt that the HT-
mediated neuroprotection was due to reduced 
cerebral metabolism. (14) Although such 
reduction does exist, there are other 
neuroprotective mechanisms. Decreasing core 
temperature, so does the metabolic rate, and in 
turn the consumption of oxygen and glucose, 
also decreases the production of carbon 
dioxide, fact that by limiting oxygen delivery, 
may help to prevent or ameliorate injury. (47) 
Electrolyte levels are affected due to tubular 
dysfunction or fluid movement between the 
intracellular and extracellular spaces. 
Although the HT appears to block 
apoptotic pathways in early stages, there is a 
small therapeutic window through which the 
HT can affect this process. (48) HT also 
reduces or ameliorates the lesion produced by 
the excitatory neurotransmission. 
Experimental evidence suggests that the HT 
decrease ICP through modulation of 
inflammatory reactions, by reducing cerebral 
metabolic rate, epileptic discharges and the 
generation of reactive oxygen species. (49–52) 
Unfortunately, such theoretical benefits 
remain as inconclusive in clinical studies. (2) 
Metodology to implement hypothermia 
There are three commonly recognized 
phases in the implementation of hypothermia: 
induction, maintenance and overheating. The 
purpose of the induction phase is to lower the 
temperature as fast as possible. In TBI, clinical 
evidence indicates that the temperature range 
associated with better outcomes appears to be 
32-35°C. (45) It is preferable to reach the 
maintenance phase quickly because the 
induction phase may be associated with 
immediate side effects such as electrolyte 
disorders, hyperglycemia, and tremor, (53) 
therefore continuous monitoring of 
ventilation, blood pressure, sedation, glucose 
and electrolytes is required. 
There are several methods for the 
induction of TH: (53) 
• Surface cooling with air: traditional 
methods such as skin exposure to air, 
which can be combined with sponge 
baths are effective, cooling blankets 
with airflow are also available.  
• Surface cooling with fluids: here are 
included ice bags, pillows or blankets 
suits with cooling air circulation, also 
circulating water pads coated with 
hydrogel.  
• Central Cooling: here are used ice-cold 
fluid infusions. More invasive devices 
such as intravascular catheters with 
balloons full of cold saline. Cold metal 
components and antipyretic drugs are 
also used. 
Desired temperature is reached more 
quickly by combining methods. (53)  
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In the maintenance phase, core 
temperature must be accurately controlled to 
maintain stability of the patient. Once at this 
stage, precautionary measures against side 
effects of HT should be taken, such as 
nosocomial infections, or pressure ulcers, 
especially if therapy is for prolonged time. 
Rewarming involves slow temperature 
increase to normal ranges, at a preferred rate 
of 0.25°C per hour. Should be slow to: (54) 
• Minimize electrolyte abnormalities as 
consequence of movement of fluid 
between the intra-and extracellular 
compartments.  
• Reduce insulin sensitivity and the risk 
of hypoglycemia in the case of 
receiving insulin the patient.  
• Prevent exacerbation of injury 
mechanisms in the injured brain as 
consequence of the rapid warming.  
• Minimizing vasodilation heating 
degree in order to maintain blood 
pressure and cerebral perfusion 
pressure. 
Hyperthermia occurs quite commonly 
after rewarming phase. Normothermia must 
be maintained because fever is independently 
associated with adverse outcomes in various 
forms of brain injury. (53,55–57) Energy crisis 
and phospholipid degradation occur very 
easily after TBI in the perilesional tissue. It has 
been demonstrated by microdialysis studies in 
patients with severe TBI that mild HT protects 
perilesional tissues better than to normal brain 
tissue, to reduce lactate/glucose, 
lactate/pyruvate ratios and glycerol levels in 
such areas. (58) Apparently, a high 
temperature appears not to alter brain 
neurochemistry substrates and adequate 
oxygen delivery, (59) however, has been 
observed that in critically ill patients 
undergoing hypothermia have less glutamate 
and lactate/pyruvate ratios, indicating that 
hypothermia can also participate. 
In an animal model of mild TBI was 
observed that hyperthermia at 39 °C for 15 
minutes before the occurrence of injury 
exacerbates the lesion, causing that mild TBI 
were vulnerable to cerebrovascular and 
metabolic processes, such as increased 
extracellular glutamate concentration, 
intracellular levels of calcium in the blood-
brain barrier and increased inflammation. (60) 
Hypothermia reduces cerebral metabolism 
during stress, reduces the release of excitatory 
neurotransmitters, and reduces the 
permeability of the blood brain barrier. (61) 
Complications 
Hypothermia can lead to several 
complications, including increased risk of 
infections, electrolyte disturbances such as 
hypokalemia, hyperkalemia, increased 
bleeding time, thrombocytopenia, 
neutropenia, acute renal failure, sepsis, 
decreased pulse, decreased cardiac output, 
hypoventilation, CNS depression, 
hyporeflexia or areflexia, bradycardia, atrial 
fibrillation, acute pulmonary edema, 
ventricular fibrillation and asystole. 
Importantly, many of these complications 
occur only in cases of severe hypothermia, 
some have been documented in moderate 
hypothermia; therefore, the current 
recommendation is the use of mild 
hypothermia. 
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Evidence 
The neuroprotective effects of HT in 
isolated injuries, more often TBI or or spinal 
cord injury have yielded conflicting results 
(mortality and functional outcome) in clinical 
trials. (62, 63) A partial explanation for such 
conflicting results derived from the different 
methodological designs used in clinical trials, 
basically these studies can be divided into 
those in which the HT was used to treat ICH 
or studies in which HT was intended to act as 
neuroprotective therapy to mediate the cease 
of biochemical and inflammatory cascade, so 
that comparisons between the studies end 
controversial. (63) 
Specifically in TBI, Harris et al., (64) in 
their meta-analysis about the role of HT in the 
management of severe TBI reported no 
benefit, indeed, Clifton et al., (65) reported a 
negative effect on the outcome of patients with 
the same severity of TBI. Polderman et al., (66) 
demonstrated the effectiveness of HT for the 
treatment of ICH in patients with severe TBI. 
In their meta-analysis, Peterson et al., (67) 
reported a statistically significant reduction in 
mortality and an increase in favorable 
neurological outcomes, the benefits were 
greater in HT maintained for more than 48 
hours, however, the increased risk of 
developing pneumonia opaque favorable 
findings.  
Hutchinson et al., (68) in its international 
multicenter study showed that in children with 
severe TBI, HT initiated within 8 hours after 
the offending event and that continued for 24 
hours does not improve neurological outcome, 
and may even increase mortality. It has also 
been shown effective not selective cooling 
systems for achieving desired temperature 
gradients. (69) Findings like these generate 
controversy, especially because there are 
compelling evidence showing benefits of HT 
in animal models, (14, 70) and human clinical 
studies have shown the beneficial impact of 
HT to reduce intracranial pressure, one of the 
cornerstones in the treatment of TBI. (27, 71, 
72) 
Georgiou et al., (73) in their meta-analysis 
on the effect of HT initiated immediately upon 
admission, mortality and neurologic outcomes 
in patients with TBI reported the association 
of HT with cerebrovascular disorders in 
rewarming, and did not identify benefits on 
mortality or neurologic morbidity. In a study 
of 37 patients with severe TBI admitted to 
ICU, Childs et al., (57) were monitored the 
behavior of the brain temperature regarding 
survival. The results support the widespread 
view that an early increase in temperature of 
patients with TBI may be associated with poor 
prognosis, but also suggest an increased risk of 
death when the temperature is consistently 
below the "normal" during the first 48h. 
The randomized clinical trial 'National 
Acute Brain Injury Study: Hypothermia II' 
(NABIS II trial) (42)  showed no beneficial 
effect on the early use of HT in patients with 
TBI, however an interesting point to consider 
is the fact that overheating was induced very 
early, probably increasing the ICP and then 
worsening outcomes. (23) Currently studies 
are underway, as the european trial 
'EUROTHERM' (ISRCTN34555414), (74) the 
Prophylactic Hypothermia Trial to Lessen 
Traumatic Brain Injury (POLAR-RCT; 
NCT00987688). 
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According to guidelines issued by the Brain 
Trauma Foundation /American Association of 
Neurological Surgeons, the optional and 
cautious use of HT in adults with TBI is a level 
III recommendation. (5) 
Conclusions 
Most of the evidence for the 
neuroprotective effects of mild to moderate 
HT derived from animal research models, 
their clinical role is still undefined, so human 
studies are needed to clarify its real therapeutic 
effect. (62) 
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